Since the present study showed that TMG-123 decreased plasma glucose levels without increasing plasma insulin levels in several animal models of T2DM (Figs 3, 4A and 4B), TMG-123 is likely to act primarily on the liver. This evidence concerns the gene INS and type 2 diabetes mellitus.